International Conference on Emerging Infectious Diseases - (ICEID-27)


11th - 12th January, 2027 | Tirana, Albania

Multi-format (In-person/Virtual)

Registration Options

Explore conference registration categories designed for every mode of participation.

Important Dates

Pre-registration Deadline

12th December, 2026

Paper Submission Deadline

17th December, 2026

Last Date Of Registration

27th December, 2026

Date Of Conference

11th - 12th January, 2027

Downloads

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 6 SDG 6 — Clean Water and Sanitation
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
SDG 10 SDG 10 — Reduced Inequalities
Explore

All Session Tracks

Track 01
Epidemiology of Emerging Infectious Diseases

This track focuses on the patterns, causes, and effects of emerging infectious diseases in populations. It aims to discuss innovative epidemiological methods and models for understanding disease dynamics.

Track 02
Antimicrobial Resistance: Challenges and Solutions

This session will explore the growing threat of antimicrobial resistance and its implications for public health. Discussions will include mechanisms of resistance, surveillance strategies, and novel therapeutic approaches.

Track 03
Zoonotic Diseases: Transmission and Control

This track will address the transmission routes and control measures for zoonotic diseases affecting human health. It will highlight interdisciplinary approaches to mitigate risks associated with cross-species infections.

Track 04
Public Health Strategies for Infectious Disease Prevention

This session will examine effective public health strategies for the prevention and control of infectious diseases. Emphasis will be placed on community engagement, vaccination programs, and health policy interventions.

Track 05
Innovations in Infectious Disease Diagnostics

This track will showcase advancements in diagnostic technologies for infectious diseases, including molecular diagnostics and rapid testing methods. Participants will discuss the impact of these innovations on timely disease detection and management.

Track 06
Infectious Diseases in Immunocompromised Hosts

This session will focus on the unique challenges posed by infectious diseases in immunocompromised individuals, including transplant recipients. Discussions will include prevention strategies and therapeutic interventions tailored for this vulnerable population.

Track 07
Tropical and Parasitic Diseases: Global Perspectives

This track will explore the epidemiology, treatment, and prevention of tropical and parasitic diseases. It aims to foster collaboration among researchers and practitioners working in endemic regions.

Track 08
Ethical Considerations in Infectious Disease Research

This session will delve into the ethical challenges faced in infectious disease research and public health interventions. Topics will include informed consent, equity in access to treatments, and the ethical implications of vaccination policies.

Track 09
Vector-Borne Diseases: Surveillance and Control

This track will address the surveillance and control strategies for vector-borne diseases, such as malaria and dengue fever. Participants will discuss the role of environmental factors and community involvement in disease management.

Track 10
Community-Acquired Infections: Trends and Treatments

This session will focus on the epidemiology and management of community-acquired infections, including pneumonia and sepsis. Emphasis will be placed on recent trends in treatment protocols and public health responses.

Track 11
Vaccination Strategies and Immunity

This track will explore the latest developments in vaccination strategies and their role in enhancing immunity against infectious diseases. Discussions will include vaccine efficacy, public acceptance, and the impact of vaccination on disease outbreaks.